Omeros Corporation Announces IPO

Market News Video
September 21, 2009 AT 10:28 AM
Clinical-stage biopharmaceutical firm Omeros said today it is launching an initial public offering of 6.82 million shares, in an estimated range of $10 to $12 per share. Omeros will be listed on the NASDAQ under the ticker symbol OMER.